Metformin, antibiotics, painkillers, and proton pump inhibitors shape the gut microbiome, including microbial signatures associated with colorectal neoplasia

BackgroundEvidence indicates that commonly prescribed drugs can alter gut microbiome composition in the short term, whereas their long-term effects remain poorly understood. Understanding these drug-microbiome interactions is important for a wide range of gut-related diseases, including colorectal cancer (CRC), and for the development of microbiome-based CRC biomarkers. ObjectiveTo examine associations between prescription drug use, the gut microbiome and screening-detected colorectal lesions, and to investigate whether drug exposure and its timing influences microbial CRC screening biomarker